Detalles de la búsqueda
1.
Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis.
Scand J Rheumatol;
53(2): 85-93, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36974977
2.
Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study.
Scand J Rheumatol;
51(6): 506-512, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726125
3.
Dysregulated Fcγ receptor IIa-induced cytokine production in dendritic cells of lupus nephritis patients.
Clin Exp Immunol;
199(1): 39-49, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31509231
4.
Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis.
Scand J Rheumatol;
48(4): 266-270, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012365
5.
Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population.
Scand J Rheumatol;
48(5): 362-366, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31244356
6.
Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration.
Scand J Rheumatol;
48(1): 17-23, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30260261
7.
Genotypes, phenotypes and treatment with immunomodulators in the rheumatic diseases.
J Intern Med;
284(3): 228-239, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908080
8.
Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL.
Lupus;
27(9): 1470-1478, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29783918
9.
Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial.
Scand J Rheumatol;
47(2): 131-140, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28862513
10.
Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.
Curr Rheumatol Rep;
20(6): 35, 2018 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29754330
11.
[Personalised medicine in rheumatology]. / Personalised medicine in de reumatologie.
Tijdschr Psychiatr;
60(3): 146-150, 2018.
Artículo
en Holandés
| MEDLINE | ID: mdl-29521400
12.
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
Ann Rheum Dis;
76(1): 96-104, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27165179
13.
Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
Ann Rheum Dis;
76(1): 126-132, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27190098
14.
The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.
Lupus;
26(10): 1051-1059, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28420054
15.
Choosing wisely in daily practice: a mixed methods study on determinants of antinuclear antibody testing by rheumatologists.
Scand J Rheumatol;
46(3): 241-246, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27471798
16.
Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.
Scand J Rheumatol;
46(2): 152-155, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27460224
17.
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Ann Rheum Dis;
75(2): 332-40, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26293163
18.
Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.
Lupus;
25(14): 1602-1609, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27334936
19.
Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care.
Lupus;
25(7): 699-709, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26936891
20.
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.
Lupus;
25(13): 1420-1430, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27055521